{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:03:18Z","timestamp":1747713798083,"version":"3.40.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejogrb.2025.113944","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:29:17Z","timestamp":1743409757000},"page":"113944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patient satisfaction with two different management modalities for erratic bleeding during continuous hormone therapy for endometriosis-associated symptoms: A before-after study"],"prefix":"10.1016","volume":"310","author":[{"given":"Yoko","family":"Zecchini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Alberico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Ambruoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pillinini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhouha","family":"Dridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-1053","authenticated-orcid":false,"given":"Giussy","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.113944_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ppe.12516","article-title":"Modifiable life style factors and risk for incident endometriosis","volume":"33","author":"Hemmert","year":"2019","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-018-0008-5","volume":"4","author":"Zondervan","year":"2018","journal-title":"Endometriosis Nat Rev Dis Primers"},{"key":"10.1016\/j.ejogrb.2025.113944_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0960-0760(02)00260-1","article-title":"Endometriosis: the pathophysiology as an estrogen-dependent disease","volume":"83","author":"Kitawaki","year":"2002","journal-title":"J Steroid Biochem Molec Biol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bpobgyn.2004.01.007","article-title":"Endometriosis: epidemiology and aetiological factors","volume":"18","author":"Vigan\u00f2","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.ejogrb.2025.113944_b0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13625187.2018.1550576","article-title":"Hormonal contraception in women with endometriosis: a systematic review","volume":"24","author":"Grandi","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2025.113944_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2016.10.022","article-title":"Estrogen-progestins and progestins for the management of endometriosis","volume":"106","author":"Vercellini","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.113944_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.113944_b0045","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/humrep\/det078","article-title":"Women\u2019s experiences with tailored use of a combined oral contraceptive: a qualitative study","volume":"28","author":"Graham","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2025.113944_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00404-015-3641-1","article-title":"Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review","volume":"292","author":"Zorbas","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2025.113944_b0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ajog.2015.08.074","article-title":"Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis","volume":"214","author":"Muzii","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/aogs.12036","article-title":"Continuous use of oral contraceptives: an overview of effects and side-effects","volume":"92","author":"Hee","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2025.113944_b0065","unstructured":"Faculty of Sexual and ReproductiveHealthcareof the Royal College of the Obstetricians and Gynaecologists. CEU clinical guidance: Problematic bleeding with hormonal contraception. London: RCOG; 2015."},{"key":"10.1016\/j.ejogrb.2025.113944_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2006.08.012","article-title":"Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials","volume":"75","author":"Mishell","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2025.113944_b0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","article-title":"Unscheduled vaginal bleeding with progestin-only contraceptive use","volume":"216","author":"Zigler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/17512433.2020.1821649","article-title":"Effects of progestin-only contraceptives on the endometrium","volume":"13","author":"Bastianelli","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"129","key":"10.1016\/j.ejogrb.2025.113944_b0085","first-page":"e1","article-title":"Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial","volume":"206","author":"Madden","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0090","first-page":"461","article-title":"The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use","volume":"92","author":"Senthong","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ejogrb.2025.113944_b0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/humrep\/dei273","article-title":"A pilot study to assess the effect of three short-term treatments on frequent and\/or prolonged bleeding compared to placebo in women using Implanon","volume":"21","author":"Weisberg","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2025.113944_b0100","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0039-128X(03)00132-6","article-title":"Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate","volume":"68","author":"Jain","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2025.113944_b0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.contraception.2016.10.001","article-title":"Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial","volume":"95","author":"Simmons","year":"2017","journal-title":"Contraception"},{"year":"2009","series-title":"Management of unscheduled bleeding in women using hormonal contraception","author":"Royal College of Obstetricians and Gynaecologists","key":"10.1016\/j.ejogrb.2025.113944_b0110"},{"key":"10.1016\/j.ejogrb.2025.113944_b0115","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0120","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.contraception.2012.08.005","article-title":"Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review","volume":"87","author":"Godfrey","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2025.113944_b0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.contraception.2013.03.014","article-title":"Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year","volume":"88","author":"Stephenson","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2025.113944_b0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.contraception.2014.10.006","article-title":"Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen","volume":"91","author":"Weisberg","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2025.113944_b0135","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.fertnstert.2005.03.083","article-title":"Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate","volume":"84","author":"Vercellini","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.113944_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2015.11.016","article-title":"Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study","volume":"105","author":"Vercellini","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.113944_b0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0150","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajog.2006.02.048","article-title":"Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen","volume":"195","author":"Sulak","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113944_b0155","article-title":"Before and after study designs","volume":"349","author":"Sedgwick","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2025.113944_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000320336","article-title":"Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin","volume":"71","author":"Zakherah","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2025.113944_b0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/humupd\/dmu046","article-title":"Systematic review of endometriosis pain assessment: how to choose a scale?","volume":"21","author":"Bourdel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2025.113944_b0170","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152500209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152500209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:14:29Z","timestamp":1747653269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121152500209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S030121152500209X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113944","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient satisfaction with two different management modalities for erratic bleeding during continuous hormone therapy for endometriosis-associated symptoms: A before-after study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113944"}}